ZB
IART icon

Zions Bancorporation’s Integra LifeSciences IART Stock Holding History

Zions Bancorporation’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-23,187
Closed -$676K – 896
2024
Q2 		$676K Sell
23,187
-796
-3% -$23.6K 0.05% 219
2024
Q1 		$850K Buy
23,983
+1,675
+8% +$67K 0.06% 218
2023
Q4 		$972K Buy
22,308
+815
+4% +$32.1K 0.07% 211
2023
Q3 		$821K Buy
21,493
+1,619
+8% +$68.1K 0.07% 209
2023
Q2 		$817K Buy
19,874
+209
+1% +$10.1K 0.07% 207
2023
Q1 		$1.13M Buy
19,665
+2,687
+16% +$151K 0.1% 169
2022
Q4 		$952K Buy
16,978
+2,004
+13% +$102K 0.08% 175
2022
Q3 		$634K Sell
14,974
-112
-0.7% -$5.74K 0.07% 200
2022
Q2 		$815K Buy
15,086
+2,935
+24% +$176K 0.08% 179
2022
Q1 		$781K Buy
12,151
+3,439
+39% +$226K 0.07% 184
2021
Q4 		$584K Buy
8,712
+1,425
+20% +$96.4K 0.05% 208
2021
Q3 		$499K Buy
7,287
+795
+12% +$56.2K 0.05% 183
2021
Q2 		$443K Buy
6,492
+906
+16% +$64.1K 0.04% 187
2021
Q1 		$386K Sell
5,586
-10
-0.2% -$677 0.04% 178
2020
Q4 		$363K Buy
5,596
+400
+8% +$21.5K 0.05% 167
2020
Q3 		$245K Buy
5,196
+204
+4% +$9.7K 0.03% 193
2020
Q2 		$235K Buy
4,992
+446
+10% +$21.9K 0.03% 191
2020
Q1 		$203K Buy
4,546
+625
+16% +$32.8K 0.04% 176
2019
Q4 		$229K Sell
3,921
-456
-10% -$27.1K 0.03% 187
2019
Q3 		$263K Buy
4,377
+18
+0.4% +$1.07K 0.04% 179
2019
Q2 		$243K Buy
4,359
+242
+6% +$12.5K 0.04% 189
2019
Q1 		$229K Buy
+4,117
New +$210K 0.04% 191
2018
Q4 		– Sell
-4,130
Closed -$272K – 623
2018
Q3 		$272K Buy
+4,130
New +$257K 0.06% 138
2018
Q2 		– Sell
-4,240
Closed -$235K – 554
2018
Q1 		$235K Buy
+4,240
New +$222K 0.05% 115
2017
Q4 		– Sell
-4,066
Closed -$205K – 775
2017
Q3 		$205K Buy
+4,066
New +$209K 0.03% 259

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Zions Bancorporation's IART Position: Q3 2024 in Review

Zions Bancorporation sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 23,187 shares — an estimated $676K sold.

Zions Bancorporation first reported a position in IART in Q3 2017 and held it in 25 quarters. The position peaked at $1.13M in Q1 2023. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

  • Zions Bancorporation reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
  • Zions Bancorporation sold 23,187 Integra LifeSciences shares in Q3 2024, an estimated $676K.
  • Zions Bancorporation first reported a position in Integra LifeSciences in Q3 2017 and held it in 25 quarters.
  • Zions Bancorporation's Integra LifeSciences position peaked at $1.13M in Q1 2023.
  • 225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on Zions Bancorporation's 13F filing for Q3 2024, filed 6 Nov 2024.